BibTex format
@article{Robertson:2020:10.1158/1078-0432.CCR-19-3387,
author = {Robertson, JFR and Evans, A and Henschen, S and Kirwan, CC and Jahan, A and Kenny, LM and Dixon, JM and Schmid, P and Kothari, A and Mohamed, O and Fasching, PA and Cheung, K-L and Wuerstlein, R and Carroll, D and Klinowska, T and Lindemann, JPO and MacDonald, A and Mather, R and Maudsley, R and Moschetta, M and Nikolaou, M and Roudier, MP and Sarvotham, T and Schiavon, G and Zhou, D and Zhou, L and Harbeck, N},
doi = {10.1158/1078-0432.CCR-19-3387},
journal = {Clinical Cancer Research},
pages = {4242--4249},
title = {A randomized, open-label, presurgical, window-of-opportunity study comparing the pharmacodynamic effects of the novel oral SERD AZD9496 with fulvestrant in patients with newly diagnosed ER+ HER2(-) primary breast cancer},
url = {http://dx.doi.org/10.1158/1078-0432.CCR-19-3387},
volume = {26},
year = {2020}
}